These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34245294)

  • 1. Nephrotic syndrome and vasculitis following SARS-CoV-2 vaccine: true association or circumstantial?
    Izzedine H; Bonilla M; Jhaveri KD
    Nephrol Dial Transplant; 2021 Aug; 36(9):1565-1569. PubMed ID: 34245294
    [No Abstract]   [Full Text] [Related]  

  • 2. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
    Hartley JL; Bailey N; Sharma A; Shawki H
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
    Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
    CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flares of mixed cryoglobulinaemia vasculitis after vaccination against SARS-CoV-2.
    Visentini M; Gragnani L; Santini SA; Urraro T; Villa A; Monti M; Palladino A; Petraccia L; La Gualana F; Lorini S; Marri S; Madia F; Stefanini L; Basili S; Fiorilli M; Ferri C; Zignego AL; Casato M
    Ann Rheum Dis; 2022 Mar; 81(3):441-443. PubMed ID: 34819272
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical and histopathological spectrum of delayed adverse cutaneous reactions following COVID-19 vaccination.
    Larson V; Seidenberg R; Caplan A; Brinster NK; Meehan SA; Kim RH
    J Cutan Pathol; 2022 Jan; 49(1):34-41. PubMed ID: 34292611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic spectrum of serious cutaneous-only adverse event following immunization with COVID-19 vaccines: a multicentre case series and literature review.
    Balogun M; Millette D; Yip V; Chan SA; Lee P; Gamal N; Hashim N; Phillips D; Walsh M; Trehan P; Hanna-Bashara L; Abdullah A; Wernham A; Tso S
    Clin Exp Dermatol; 2022 Mar; 47(3):614-616. PubMed ID: 34748655
    [No Abstract]   [Full Text] [Related]  

  • 7. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination.
    Lee EJ; Cines DB; Gernsheimer T; Kessler C; Michel M; Tarantino MD; Semple JW; Arnold DM; Godeau B; Lambert MP; Bussel JB
    Am J Hematol; 2021 May; 96(5):534-537. PubMed ID: 33606296
    [No Abstract]   [Full Text] [Related]  

  • 8. Abrupt onset of Sweet syndrome, pityriasis rubra pilaris, pityriasis lichenoides et varioliformis acuta and erythema multiforme: unravelling a possible common trigger, the COVID-19 vaccine.
    Sechi A; Pierobon E; Pezzolo E; Germi L; Trevisan G; Zardo D; Riva G; Mondino S; Naldi L
    Clin Exp Dermatol; 2022 Feb; 47(2):437-440. PubMed ID: 34617317
    [No Abstract]   [Full Text] [Related]  

  • 9. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
    Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
    G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of myocarditis and pericarditis after a COVID-19 mRNA vaccine booster and after COVID-19 in those with and without prior SARS-CoV-2 infection: A self-controlled case series analysis in England.
    Stowe J; Miller E; Andrews N; Whitaker HJ
    PLoS Med; 2023 Jun; 20(6):e1004245. PubMed ID: 37285378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune thrombocytopenia in a 22-year-old post Covid-19 vaccine.
    Tarawneh O; Tarawneh H
    Am J Hematol; 2021 May; 96(5):E133-E134. PubMed ID: 33476455
    [No Abstract]   [Full Text] [Related]  

  • 12. Myocarditis after vaccination against covid-19.
    Gellad WF
    BMJ; 2021 Dec; 375():n3090. PubMed ID: 34916217
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptoms After COVID-19 Vaccination in Patients With Persistent Symptoms After Acute Infection: A Case Series.
    Arnold DT; Milne A; Samms E; Stadon L; Maskell NA; Hamilton FW
    Ann Intern Med; 2021 Sep; 174(9):1334-1336. PubMed ID: 34029484
    [No Abstract]   [Full Text] [Related]  

  • 14. New onset and exacerbation of oral lichenoid mucositis following SARS-CoV-2 infection or vaccination.
    Alabdulaaly L; Sroussi H; Epstein JB
    Oral Dis; 2022 Nov; 28 Suppl 2():2563-2567. PubMed ID: 35595719
    [No Abstract]   [Full Text] [Related]  

  • 15. COVID-19 vaccination-related small vessel vasculitis with multiorgan involvement.
    Kim Y; Kang J; Lee SG; Kim GT
    Z Rheumatol; 2022 Aug; 81(6):509-512. PubMed ID: 35587834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombocytopenia after COVID-19 vaccination.
    Kragholm K; Sessa M; Mulvad T; Andersen MP; Collatz-Christensen H; Blomberg SN; Lippert F; Mikkelsen S; Leutscher P; Melgaard D; Torp-Pedersen C; Kristensen SR; Larsen TB; Sogaard P
    J Autoimmun; 2021 Sep; 123():102712. PubMed ID: 34332437
    [No Abstract]   [Full Text] [Related]  

  • 17. Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine.
    Yamamoto S; Fukunaga A; Tanaka A; Takeuchi JS; Inoue Y; Kimura M; Maeda K; Ueda G; Mizoue T; Ujiie M; Sugiura W; Ohmagari N
    Vaccine; 2022 Mar; 40(13):1924-1927. PubMed ID: 35183384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgA vasculitis presenting as nephrotic syndrome following COVID-19 vaccination: a case report.
    Cho I; Kim JK; Kim SG
    BMC Nephrol; 2022 Dec; 23(1):403. PubMed ID: 36522629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bell's palsy following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines: a case series and nested case-control study.
    Wan EYF; Chui CSL; Lai FTT; Chan EWY; Li X; Yan VKC; Gao L; Yu Q; Lam ICH; Chun RKC; Cowling BJ; Fong WC; Lau AYL; Mok VCT; Chan FLF; Lee CK; Chan LST; Lo D; Lau KK; Hung IFN; Leung GM; Wong ICK
    Lancet Infect Dis; 2022 Jan; 22(1):64-72. PubMed ID: 34411532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.